LILRB4 and cardiac hypertrophy: Overexpression of LILRB4 in the heart attenuates cardiac hypertrophy, fibrosis and dysfunction in response to pressure overload, and it inhibits angiotensin II-induced cardiomyocyte hypertrophy in vitro.